BioTime (LCTX) mit Buy rating
Seite 1 von 1 Neuester Beitrag: 01.06.21 17:10 | ||||
| Eröffnet am: | 05.01.20 16:53 | von: moneywork4. | Anzahl Beiträge: | 9 |
| Neuester Beitrag: | 01.06.21 17:10 | von: Balu4u | Leser gesamt: | 4.460 |
| Forum: | Hot-Stocks | Leser heute: | 2 | |
| Bewertet mit: |  | |||
Zu Biotime:
AMD affects more than 30 million people worldwide and approximately 1.6 million people are newly diagnosed annually in the U.S.1 It is a leading cause of vision loss in people over the age of 60 in the developed world. There are two forms of AMD: “wet AMD,” which affects only 10% of patients and “dry AMD,” which affects 90% of patients.2 Currently, there are only two FDA-approved therapies for the less common wet AMD, yet they constitute an estimated $6 billion dollar market.3
https://lineagecell.com/products-pipeline/opregen/
https://lineagecell.com/
Optionen
| Boardmail an "Balu4u" |
Wertpapier: Lineage Cell Therapeuti |